Global Cytogenetic Systems Demand is anticipated to be valued at USD 1,688.5 Million in 2022, forecast to grow at a CAGR of 11.0% to be valued at USD 5,327.8 Million from 2022 to 2032. Growth is attributed to the increase in incidence of genetic disorders and cancer.
| Report Attribute | Details |
|---|---|
| Growth Rate (2016 to 2021) | 8.5% CAGR |
| Expected Market Value (2022) | USD 1,688.5 Million |
| Anticipated Forecast Value (2032) | USD 5,327.8 Million |
| Projected Growth Rate (2022 to 2032) | 11.0% CAGR |
Cytogenetics is a branch of genetics dealing with the study of number and structure of human and animal chromosomes. It offers various applications in terms of diagnosis and treatment of diseases such as cancer and genetic disorders such as Down syndrome and Cri du Chat syndrome. Cytogenetic systems are the equipment designed to carry out cytogenetic analyses.
It can help detect risk of common aneuploidies (phenomenon of having extra or missing chromosomes) and syndromes due to chromosomal structural abnormalities. Diagnosis and treatment of many leukemia, lymphomas, and solid tumors depends on cytogenetic analysis of specific chromosomal anomalies.
The Increasing incidence of cancer and related growth in mortality per year are the major factors that are expected to boost the growth of the cytogenetic systems market during the forecast period.
On the other hand, high cost of cytogenetic instruments is one of the major factors that is expected to hamper the growth of Cytogenetic Systems market over the analysis period.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The rising demand of early diagnosis of severe life-threatening diseases such as cancer and diagnosis of disorders due to chromosomal anomalies in developing embryos, is one of the major factors that is expected to augment the growth of the Cytogenetic Systems market over the analysis period.
In addition, expansion of geriatric population pool, rising exposure to dangerous chemicals and ultraviolet rays, increase in numbers of people adopting bad habits such as smoking and drinking and the sedentary lifestyle are some other factors that are anticipated to accelerate the growth of the market in the near future.
The growth of the global cytogenetics market is majorly driven by increase in incidence of genetic disorders and cancer. Other factors boosting the market growth include increase in focus on targeted cancer treatment, rise in aging population, and increase in prevalence of chronic diseases. Conversely, transition from fluorescence in situ hybridization to array based is expected to provide lucrative growth opportunities for the global market.
There are some factors which are expected to impede the growth of the Cytogenetic Systems market over the analysis period, such as technical limitations and complexities associated with the equipment.
However, high cost of cytogenetic instruments, and lack of awareness about advanced technological methodologies, especially in low and middle income countries and high cost of sophisticated devices are also expected to hinder the market growth during the forecast period.
In terms of regional platform, North America holds a significant market share in Cytogenetic Systems market. The region is expected to surge at over 42.1% share from 2022 to 2032.
North America is expected to witness promising growth, attributed to rising awareness about molecular cytogenetics, growing number of diagnostic laboratories and research institutions focused on cytogenetics in the region.
According to Future Market Insights, Europe is expected to provide immense growth opportunities for Cytogenetic Systems, and is expected to reach at a highest share of 27.3% in 2022.
Europe is expected to witness the largest market growth, owing to the presence of a huge population in need, high birth rate, rising caseload of pre and postnatal disorders, and increasing number of cases of different types of cancer.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
There are many prominent market players in the cytogenetic systems market, working hand-in-hand to provide the best-in-class cytogenetic systems for enhancing the global cytogenetic arena. However, there are many global start-ups in the cytogenetic systems market, who are stepping forward in matching the requirements of the cytogenetic systems domain.
Global Startups of Cytogenetic Systems Market:
Some of the key participants present in the global Cytogenetic Systems market include ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., MetaSystems, Agilent Technologies, Cytocell Ltd, Leica Biosystems Nussloch GmbH, Applied Spectral Imaging, Irvine Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc. and Abbott Laboratories, among others.
Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., and MetaSystems account for a considerable market size, several regional level players are also operating across key growth regions, particularly in North America.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 11.0% from 2022 to 2032 |
| Market Value in 2022 | USD 1,688.5 Million |
| Market Value in 2032 | USD 5,327.8 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Technology, Application, End User, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, GCC, South Africa, Israel |
| Key Companies Profiled | ADS Biotec Inc.; Harris Computer Systems; Laboratory Imaging s.r.o; MetaSystems; Agilent Technologies; OGT Ltd.; Leica Biosystems Nussloch GmbH; Applied Spectral Imaging; PerkinElmer Inc.; Bio-Rad Laboratories; Abbott Laboratories |
| Customization | Available Upon Request |
FMI projects the global cytogenetic systems market to expand at an 11.0% value CAGR by 2032
North America is expected to be the most opportunistic Cytogenetic Systems market, accumulating a 42.1% revenue share
ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., and MetaSystems are some prominent Cytogenetic Systems manufacturers
| Estimated Size, 2025 | USD 17,753.7 million |
|---|---|
| Projected Size, 2035 | USD 29,169.1 million |
| CAGR (2025 to 2035) | 5.1% |
| Expected Market Value (2022) | USD 2,761.9 Million |
|---|---|
| Anticipated Forecast Value (2032) | USD 6,469.2 Million |
| Projected Growth Rate (2022 to 2032) | 8.9% CAGR |
| Expected Market Value (2022) | USD 13,803.92 Million |
|---|---|
| Anticipated Forecast Value (2032) | USD 32,978.94 Million |
| Projected CAGR (2022 to 2032) | 9.1% |
Explore Life Science & Biotechnology Insights
View Reports
Cytogenetic Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
